Predicting Response to Anthracyclines in Ovarian Cancer

(1) Background: Anthracyclines are intriguing drugs, representing one of the cornerstones of both first and subsequent-lines of chemotherapy in ovarian cancer (OC). Their efficacy and mechanisms of action are related to the hot topics of OC clinical research, such as BRCA status and immunotherapy. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrero, Annamaria, Borghese, Martina, Restaino, Stefano, Puppo, Andrea, Vizzielli, Giuseppe, Biglia, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998349/
https://www.ncbi.nlm.nih.gov/pubmed/35409939
http://dx.doi.org/10.3390/ijerph19074260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998349/
https://www.ncbi.nlm.nih.gov/pubmed/35409939
http://dx.doi.org/10.3390/ijerph19074260

Ejemplares similares